Home › Funds › Penn Capital Management Company, LLC › LGND

Penn Capital Management Company, LLC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

Penn Capital Management Company, LLC reported holding 98,747 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$30.9M, representing 2.29% of its reported portfolio and ranking #1 among its reported holdings. Penn Capital Management Company, LLC has disclosed LGND holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)98.75K sh
Reported value held$30.88M
Portfolio Weight2.29%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Penn Capital Management Company, LLC's LGND position evolved

Penn Capital Management Company, LLC first disclosed a stake in LGND in Q3 2024 at 100,218 shares (US$10.0M). The position peaked in Q2 2026 at 100,337 shares, worth US$31.7M. Across 9 filings, Penn Capital Management Company, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 98,747 shares valued at US$30.9M — a reduction of -1,590 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2024 100.22K $10.04M New
Q4 2024 104.43K $11.19M Add
Q1 2025 120.84K $12.72M Add
Q2 2025 120.38K $13.70M Hold
Q3 2025 107.28K $19.02M Reduce
Q4 2025 98.85K $18.71M Reduce
Q1 2026 95.46K $19.08M Reduce
Q2 2026 100.34K $31.75M Add
Q3 2026 98.75K $30.88M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has Penn Capital Management Company, LLC held LGND?

Penn Capital Management Company, LLC has disclosed LGND holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Penn Capital Management Company, LLC's current position in LGND?

As of Q3 2026, Penn Capital Management Company, LLC holds 98.75K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $30.88M, representing 2.29% of its reported portfolio and ranking #1.

Has Penn Capital Management Company, LLC been buying or selling LGND?

In the latest 13F filing (Q3 2026), Penn Capital Management Company, LLC reduced its position in LGND. The position peaked in Q2 2026 at 100.34K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.